Risk of Business Disruptions and Performance Impacts from the Spread of COVID-19
First written in FY2020. 6 of 9 entries say "Restated". Latest entry: FY2024.
5 other companies' latest entry also says "Dropped".
- FY2024DroppedAnnual report
「COVID-19 was reclassified as a Category V infectious disease, and inbound demand exceeding pre-COVID levels and a gradual recovery in domestic demand were observed,」
The risk of business stagnation and an impact on performance due to a prolonged spread of infection, which had been described through the previous fiscal year, is not separately listed among the risks relating to the business and other matters for the current fiscal year. - FY2023SoftenedAnnual report
「For the fiscal year ending March 2024, COVID-19 was downgraded to Category V under the Infectious Diseases Control Law and treated in the same manner as seasonal influenza, and the impact of COVID-19 was expected to subside.」
While indicating that the impact of COVID-19 is expected to subside, the company retains the possibility of an impact on performance if infections rise explosively again. - FY2022RestatedAnnual report
「It is extremely difficult to predict the duration of the effects of the spread of infection and when the global economy will stabilize, and depending on the circumstances, customers' capital investment could stagnate and affect the company's performance.」
The company continues to identify the uncertainty over the duration of the impact of the pandemic and when it will subside, stagnation in customers' capital investment, and the risk of an impact on performance. - FY2022-Q3RestatedAnnual report
「If the impact on economic activity persists longer than expected, the decline in the valuation of investment securities and concerns about the collection of trade receivables could affect the company's performance.」
The company continues to describe the decline in the valuation of investment securities and concerns about the collection of trade receivables resulting from a prolonged impact of COVID-19 as risks affecting performance. - FY2022-Q2RestatedAnnual report
「If the impact on economic activity persists longer than expected, the decline in the valuation of investment securities and concerns about the collection of trade receivables could affect the company's performance.」
The company continues to describe the decline in the valuation of investment securities and concerns about the collection of trade receivables if the impact of COVID-19 is prolonged as risks affecting performance. - FY2021RestatedAnnual report
「It is extremely difficult to predict when the effects of the spread of COVID-19 will subside, and depending on the timing, the company's performance could be affected.」
The company continues to describe the uncertainty over how long the spread of infection will continue and when it will subside, as well as the risk of an impact on sales and performance. - FY2021-Q3RestatedAnnual report
「If the impact on economic activity persists, the decline in the valuation of investment securities and concerns about the collection of trade receivables could affect the company's performance.」
The company continues to describe the decline in the valuation of investment securities and concerns about the collection of trade receivables if the impact of COVID-19 is prolonged as risks affecting performance. - FY2021-Q1RestatedAnnual report
「If the impact on economic activity persists longer than expected, the decline in the valuation of investment securities and concerns about the collection of trade receivables could affect the company's performance.」
The company specifically describes the decline in the valuation of investment securities and concerns about the collection of trade receivables if the spread of COVID-19 is prolonged as existing risks. - FY2020First statedAnnual report
「If an employee or temporary worker becomes infected, there is a risk that operations may be disrupted, including through the closure of business locations. In addition, if the effects of the spread of COVID-19 persist, the resulting slowdown in economic activity could affect the company's performance, including through a decline in sales.」
The company newly describes the closure of business locations and operational disruption caused by infections, and the decline in sales and impact on performance caused by a prolonged spread of infection, as risks. The main text also explains that the company has already been affected to some extent by the economic downturn caused by the spread of infection.